Stability of microarray patches for transdermal delivery of the nucleoside reverse transcriptase translocation inhibitor Islatravir for HIV treatment
HIV remains a global health challenge, affecting 39 million people worldwide, with the highest prevalence in Africa. Infants under one year old are particularly at risk, underscoring the need for effective and well-tolerated antiretroviral treatments, as well as preventive measures such as pre-exposure prophylaxis (PrEP), which plays a crucial role in HIV prevention strategies.<br/><br/>
Authors
- Akmal Hidayat Sabri
- Robert K.M Choy
- Ryan F. Donnelly (ORCID: https://orcid.org/0000-0002-0766-4147)
- Natalia N. Porfiryeva (ORCID: https://orcid.org/0000-0002-7110-2093)
- Priscilla Kwarteng
- Jessica Mistilis
- Anjali; id_orcid 0000-0002-9010-0739 Pandya
- Fabiana Volpe-Zanutto
- Lalitkumar K.; id_orcid 0000-0001-8106-9066 Vora
Institutions
- Program for Appropriate Technology in Health (IN)
Publication Details
- Journal
- Research Portal (Queen's University Belfast)
- Published
- 2025-03-25
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00